Charles River Laboratories International (CRL) Non-Current Assets (2009 - 2025)
Charles River Laboratories International (CRL) recorded quarterly Non-Current Assets of $5.7 billion in Q4 2025, down 4.9% quarter-over-quarter from $6.0 billion in Q3 2025, and down 7.13% on a YoY basis from $6.1 billion in Q4 2024.
Charles River Laboratories International (CRL) Non-Current Assets (2009 - 2025) Analysis & Trends
Charles River Laboratories International's Non-Current Assets history runs 17 years deep, the most recent figure standing at $5.7 billion for Q4 2025.
- In Q4 2025, Non-Current Assets fell 7.13% year-over-year to $5.7 billion; the TTM figure through Dec 2025 stood at $23.8 billion (down 6.77% YoY), while the FY2025 annual figure was $5.7 billion, down 7.13% from the prior year.
- Non-Current Assets was $5.7 billion for Q4 2025 at Charles River Laboratories International, down from $6.0 billion in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $6.6 billion in Q4 2023 to a low of $4.4 billion in Q1 2021.
- Historically, Non-Current Assets has averaged $6.0 billion across 5 years, with a median of $6.1 billion in 2024.
- The sharpest annual moves came in 2021 and 2025: Non-Current Assets soared 36.1% in 2021, then decreased 8.1% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $5.8 billion in 2021, then grew by 7.19% to $6.2 billion in 2022, then climbed by 6.86% to $6.6 billion in 2023, then declined by 7.0% to $6.1 billion in 2024, then decreased by 7.13% to $5.7 billion in 2025.
- The last three Non-Current Assets figures came in at $5.7 billion (Q4 2025), $6.0 billion (Q3 2025), and $6.1 billion (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 20.47 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 90.97 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 69.61 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 1.93 Bn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 8.30 Bn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 23.46 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 962.59 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 3.82 Bn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 2.34 Bn |
| 10 | Charles River Laboratories International | 9.26 Bn | 9.06 Bn | 744.94 Mn | 5.69 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | 5.69 Bn |
| Sep 27, 2025 | 5.98 Bn |
| Jun 28, 2025 | 6.09 Bn |
| Mar 29, 2025 | 6.08 Bn |
| Dec 28, 2024 | 6.13 Bn |
| Sep 28, 2024 | 6.51 Bn |
| Jun 29, 2024 | 6.45 Bn |
| Mar 30, 2024 | 6.48 Bn |
| Dec 30, 2023 | 6.59 Bn |
| Sep 30, 2023 | 6.16 Bn |
| Jul 1, 2023 | 6.27 Bn |
| Apr 1, 2023 | 6.25 Bn |
| Dec 31, 2022 | 6.16 Bn |
| Sep 24, 2022 | 5.97 Bn |
| Jun 25, 2022 | 6.14 Bn |
| Mar 26, 2022 | 5.74 Bn |
| Dec 25, 2021 | 5.75 Bn |
| Sep 25, 2021 | 5.68 Bn |
| Jun 26, 2021 | 5.45 Bn |
| Mar 27, 2021 | 4.39 Bn |